JFS Wealth Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$406 Buy
+16
New +$364 ﹤0.01% 2002
2024
Q1
Sell
-15
Closed -$140 2020
2023
Q4
$140 Sell
15
-35
-70% -$362 ﹤0.01% 1935
2023
Q3
$636 Buy
50
+15
+43% +$206 ﹤0.01% 1699
2023
Q2
$498 Sell
35
-19
-35% -$267 ﹤0.01% 1760
2023
Q1
$806 Sell
54
-4
-7% -$61 ﹤0.01% 1634
2022
Q4
$862 Buy
58
+5
+9% +$82 ﹤0.01% 1636
2022
Q3
$1K Buy
53
+12
+29% +$242 ﹤0.01% 1589
2022
Q2
$1K Buy
41
+18
+78% +$367 ﹤0.01% 1580
2022
Q1
$1K Buy
23
+5
+28% +$122 ﹤0.01% 1679
2021
Q4
$0 Buy
+18
New +$482 ﹤0.01% 1815
2016
Q3
Sell
-3,200
Closed -$232K 504
2016
Q2
$232K Buy
+3,200
New +$220K 0.06% 138

Other funds holding MD

JFS Wealth Advisors's MD Position: Q2 2026 in Review

JFS Wealth Advisors opened a new position in Pediatrix Medical (MD) in Q2 2026: 16 shares worth $406. The stake represents ﹤0.01% of the portfolio and ranks #2002 among its holdings. This is a return to the name: JFS Wealth Advisors previously reported a position in MD as recently as Q4 2023.

JFS Wealth Advisors first reported a position in MD in Q2 2016 and has held it in 11 quarters since. The position peaked at $232K in Q2 2016. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • JFS Wealth Advisors held 16 shares of Pediatrix Medical worth $406 as of Q2 2026.
  • Pediatrix Medical was a new JFS Wealth Advisors position in Q2 2026.
  • Pediatrix Medical made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #2002 holding.
  • JFS Wealth Advisors first reported a position in Pediatrix Medical in Q2 2016 and has held it in 11 quarters since.
  • JFS Wealth Advisors's Pediatrix Medical position peaked at $232K in Q2 2016.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.